Provided by Tiger Trade Technology Pte. Ltd.

iShares U.S. Pharmaceuticals ETF

100.86
-0.6761-0.67%
Volume:59.43K
Turnover:5.98M
Market Cap:1.61B
PE:9.39
High:101.91
Open:101.91
Low:100.34
Close:101.53
52wk High:108.66
52wk Low:69.02
Shares:16.00M
Float Shares:16.00M
Volume Ratio:1.23
T/O Rate:0.37%
Dividend:1.47
Dividend Rate:1.45%
EPS(TTM):10.74
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Eli Lilly is Maintained at Reduce by HSBC

Dow Jones
·
Sep 10

Eli Lilly’s GLP-1 Windfall to Fund Push into Women’s Health - Bloomberg News

Reuters
·
Sep 10

Johnson & Johnson receives CE Marking for ACUVUE OASYS MAX

TIPRANKS
·
Sep 10

Johnson & Johnson Receives Ce Marking for Acuvue Oasys Max Reusable Contact Lenses

THOMSON REUTERS
·
Sep 10

Bloomsbury Executives Adjust Holdings After 2023 Share Plan Vesting

TIPRANKS
·
Sep 10

HSBC Adjusts Price Target on Eli Lilly and Co. to $940 From $850, Keeps Reduce Rating

MT Newswires Live
·
Sep 10

Merck Price Target Raised to $161.00/Share from $127.00 by Leerink Partners

Dow Jones
·
Sep 10

Analysts Have Conflicting Sentiments on These Healthcare Companies: Bristol-Myers Squibb (BMY), Stryker (SYK) and InnovAge Holding (INNV)

TIPRANKS
·
Sep 09

Tyra Biosciences Stock Plunges 22% as Bladder Cancer Pill Fails to Impress

Dow Jones
·
Sep 09

BRAIN Biotech Receives EUR 11.51 Million Milestone Payment from Royalty Pharma

Reuters
·
Sep 09

Leerink Partners Adjusts Price Target on Merck & Co. to $161 From $127, Keeps Outperform Rating

MT Newswires Live
·
Sep 09

Merck & Co Inc : Leerink Partners Raises Target Price to $161 from $127

THOMSON REUTERS
·
Sep 09

Merck price target raised to $161 from $127 at Leerink

TIPRANKS
·
Sep 09

CD&R Appoints Novartis Chair Giovanni Caforio Operating Advisor to Funds

Reuters
·
Sep 09

Analysts Conflicted on These Healthcare Names: Amgen (AMGN), Beam Therapeutics (BEAM) and Royalty Pharma (RPRX)

TIPRANKS
·
Sep 09

Atai Beckley Holds Shareholder Meeting, Quorum Met with 65.6% Shares Represented

Reuters
·
Sep 09

Medtronic PLC Stock Outperforms Competitors Despite Losses on the Day

Dow Jones
·
Sep 09

Bristol Myers Squibb Co. Stock Underperforms Tuesday When Compared to Competitors

Dow Jones
·
Sep 09

Merck & Co. Inc. Stock Outperforms Competitors Despite Losses on the Day

Dow Jones
·
Sep 09

Protagonist Therapeutics Launches USD 300 Million Share Buyback Program

Reuters
·
Sep 09